ArticleCancers2023

Peptidylarginine Deiminase Type 2 Predicts Tumor Progression and Poor Prognosis in Patients with Curatively Resected Biliary Tract Cancer.

Hon-Yi Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.